Small-Cap Biotech Surges Almost 350% on Cancer-Drug Trial Data

(Bloomberg) — Small-cap drug developer Five Prime Therapeutics Inc. is on track to post one of this year’s biggest daily stock moves after reporting promising data from a mid-stage cancer study.The South San Francisco, California-based biotech firm skyrocketed as much as 349% after a combination of its drug and chemotherapy helped some patients keep their stomach cancer at bay for longer than those receiving just chemotherapy. Should this rally hold, it would be the third biggest single-day move on the New York Stock Exchange and Nasdaq Exchange, according to data compiled by Bloomberg.Its stock-surge trails a pair of micro-caps with …read more

Source:: Yahoo Finance


Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.